Abstract
Background
Depressive disorder encompasses a wide spectrum of somatic and psychological symptoms. It is not known whether there are differences regarding the cluster of depressive symptomatology between subjects with depression with and without T2DM.
Purpose
To explore whether the cluster of depression that prevails among depressive subjects with T2DM differs from individuals with depression, but without T2DM.
Methods
87 T2DM patients with a pathological Beck Depression Inventory test (BDI) were compared with 50 age- and gender-matched individuals with a major depressive disorder. All 21 items expressed in the BDI were compared between the two groups.
Results
The score obtained after administering the BDI was comparable between patients with T2DM and significant depressive symptoms and the control group (18.8 ± 2.7 vs 18.9 ± 3.4; p = 0.9). Subjects with T2DM had higher scores compared with the control group in the following items: sadness (1.4 ± 0.9 vs 0.9 ± 0.9; p = 0.011), difficulty in concentration (1.3 ± 0.8 vs 0.8 ± 0.8; p = 0.01), indecisiveness (1.1 ± 0.8 vs 0.5 ± 0.9; p = 0.012), worries about their health (1.3 ± 0.9 vs 0.6 ± 0.9; p < 0.0001), fatigue (1.2 ± 0.6 vs 0.8 ± 0.7; p = 0.003) and loss of sexual appetite (2.7 ± 0.6 vs 1.2 ± 1.3; p = 0.0001). Suicidal ideation was significantly lower among subjects with T2DM compared with the control group (0.1 ± 0.3 vs 0.6 ± 0.8; p = 0.0001).
Conclusions
Subjects with T2DM and a positive screening for depression presented a different cluster of depression compared with depressed subjects without T2DM, with a predominance of somatic–biological depressive symptoms rather than psychological–cognitive cluster and negative emotions, such as suicidal ideation.
Similar content being viewed by others
References
World Health Organization (2005) Revised global burden of disease (GBD) 2002 estimates. http://www.who.int/healthinfo/global_burden_disease/en/index.html. Accessed 18 Feb 2019
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:851–858
Roy T, Lloyd CE (2012) Epidemiology of depression and diabetes: a systematic review. J Affect Disord 142(Suppl):S8–S21
Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ et al (2010) Prevalence of comorbid depression is high in out-patients with type 1 or type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med 27:217–224
Li C, Ford ES, Strine TW et al (2008) Prevalence of depression among US adults with diabetes: findings from the 2006 behavioural risk factor surveillance system. Diabetes Care 31:105–107
Lloyd CE, Roy T, Nouwen A et al (2012) Epidemiology of depression in diabetes: international and cross-cultural issues. J Affect Disord 142(Suppl):S22–S29
Castro-Costa E, Dewey M, Stewart R et al (2007) Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study. Br J Psychiatry 191:393–401
Copeland JR, Beekman AT, Braam AW et al (2004) Depression among older people in Europe: the EURODEP studies. World Psychiatry 3:45–49
Nicolau J, Simó R, Sanchís P, Ayala L, Fortuny R, Rivera R, Masmiquel L (2016) Prevalence and clínical correlators of undiagnosed significant depressive symptoms among individuals with type 2 diabetes in a Mediterranean population. Exp Clin Endocrinol Diabetes 124:1–7
Finkelstein EA, Bray JW, Chen H et al (2003) Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26:415–420
Egede LE, Zheng D, Simpson K (2002) Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25:464–470
de Groot M, Anderson R, Freedland KE et al (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630
Katon WJ, Young BA, Russo J et al (2013) Association of depression with increased risk of severe hypoglycaemic episodes in patients with diabetes. Ann Fam Med 11:245–250
Duru NS, Civilibal M, Elevli M (2016) Quality of life and psychological screening in children with type 1 diabetes and their mothers. Exp Clin Endocrinol Diabetes 124:105–110
Richardson LK, Egede LE, Mueller M et al (2008) Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes. Gen Hosp Psychiatry 30:509–514
Aikens JE, Perkins DW, Lipton B et al (2009) Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes. Diabetes Care 32:1177–1181
de Groot M, Jacobson AM, Samson JA et al (1999) Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 46:425–435
Lustman PJ, Clouse RE, Nix BD et al (2006) Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 63:521–529
Lustman PJ, Freedland KE, Griffith LS et al (2000) Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23:618–623
Amsterdam JD, Shults J, Rutherford N et al (2006) Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus. Neuropsychobiology 54:208–214
Paile-Hyvaärinen M, Wahlbeck K, Eriksson JG (2007) Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract 8:34–37
Ghaeli P, Shahsavand E, Mesbahi M et al (2004) Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. Clin Psychopharmacol 24:386–388
Nicolau J, Rivera R, Francés C et al (2013) Treatment of depression in type 2 diabetic patients: effects on depressive symptoms, quality of life and metabolic control. Diabetes Res Clin Pract 101:148–152
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders DSM-V, 5th edn. American Psychiatric Publishing, Arlington
Lux V, Kendler KS (2010) Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria. Psychol Med 40:1679–1690
de Jonge P (2011) Depression deconstruction lessons from psychosomatic research. J Psychosom Res 71:59–60
Beck AT, Steer RA, Brown GA (1996) Beck Depression Inventory-II (BDI-II). Manual. Pearson, Oxford
Lustman PJ, Clouse RE, Griffith LS et al (1997) Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 59:24–31
Chatterjee S, Khunti K, Davies M (2017) Type 2 diabetes. Lancet 389:2239–2251
Gomis R, Artola S, Conthe P, Vidal J, Casamor R, Font B, Grupo de Estudio OBEDIA (2014) Prevalencia de diabetes mellitus tipo 2 en pacientes ambulatorios con sobrepeso u obesidad en España. Estudio OBEDIA. Med Clin 142:485–492
Rajan TM, Menon V (2017) Psychiatric disorders and obesity: a review of association studies. J Postgrad Med 63:182–190
Jantaratnotai N, Mosikanon K, Lee Y, McIntyre RS (2017) The interface of depression and obesity. Obes Res Clin Pract 11:1–10
Han SJ, Kim HJ, Choi YJ, Lee KW, Kim DJ (2013) Increased risk of suicidal ideation in Korean adults with both diabetes and depression. Diabetes Res Clin Pract 101:e14
ten Have M, de Graaf R, van Dorsselaer S, Verdurmen J, Van Land H, Vollebergh W (2009) Incidence and course of suicidal ideation and suicide attempts in the general population. Can J Psychiatry 54:824–833
Handley TE, Inder KJ, Kay Lambkin FJ, Stain HJ, Fitzgeranld M, Lewin TJ (2012) Contributors to suicidality in rural communities: beyond the effects of depression. BMC Psychiatry 12:105
Ceretta LB, Reus GZ, Abelaira HM, Jornada LK, Schwalm MT, Hoepers NJ (2012) Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients. Acta Diabetol 49(Suppl 1):S227–S234
Wang B, An X, Shi X, Zhang J (2017) Suicide risk in patients with diabetes: a systematic review and meta-analysis. EJE 177:R169–R181
De Ridder D, Geenen R, Kuijer R, van Middendorp H (2008) Psychological adjustment to chronic disease. Lancet 372:246–255
Ehrmann D, Schmitt A, Reimer A, Haak T, Kulzer B, Hermanns N (2017) The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes. Acta Diabetol 54:749–756
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the Ethics Committee of the Hospital Son Llàtzer.
Informed consent
Written informed consent was obtained for both groups prior to study participation.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nicolau, J., Simó, R., Conchillo, C. et al. Differences in the cluster of depressive symptoms between subjects with type 2 diabetes and individuals with a major depressive disorder and without diabetes. J Endocrinol Invest 42, 881–888 (2019). https://doi.org/10.1007/s40618-019-01020-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-019-01020-x